Plaintiffs from 7 states have filed personal injury suits against Pfizer for alleged undisclosed risks of the popular cholesterol-blocking drug Lipitor. Read the full story here: Lipitor Litigation
Disclaimer: The content found on the TotalInjury Blog is not legal advice and is purely for informational purposes. Total Injury, Inc. does not guarantee the accuracy, integrity or quality of submissions. The information provided by the bloggers on this site may not represent the opinions of the site editor(s), Total Injury, Inc. or its affiliates. The information contained herein is not a substitute for the advice of an attorney. For additional disclaimers, please visit our Terms & Conditions. All photos are of models and do not depict clients.
Eli Lilly 3Q 10% profit rise is nearly all from psyche drugs including zyprexa.
How have they schemed to squeeze more money from their zyprexa cash cow when pill production has actually gone down?
ANS-Eli Lilly profiteers have jacked up the price of zyprexa to the federal govt,from the Medicare D payouts.
Eli Lilly is a big drug company that puts profits over patients.
They covered up findings that their Zyprexa has a TEN times greater risk of causing type 2 diabetes
Only 9% of Americans trust big pharma,right around the same rating as tobacco companies.
Daniel Haszard Eli Lilly zyprexa drug caused my diabetes http://www.zyprexa-victims.com
MY STORY:
I received a type of chemotherapy in 2004 called Taxotere. The drug is manufactured by Sanofi-Aventis and is used in the treatment of breast cancer. Taxotere causes permanent hair loss in approximately 6.3 of patients. I am in communication with a group of approximately 40-50 women who suffer permanent hair loss from this drug, however, I believe that we are less than 10% of the 6.3% who are affected. At least 10,000 people have been treated with this drug worldwide (as of 2008), which would make the number closer to 500+. It is my belief, and there is evidence, that Sanofi-Aventis has known about the permanent hair loss as early as the trials in 2002/2003, but chose not to disclose this information to Oncologists and consequently their patients. To this day, it is not mentioned on the website http://www.taxotere.com . When I underwent Herceptin treatment, another type of chemotherapy, I was informed that there was a risk of heart damage and decided to go ahead with the treatment, but it was MY decision. My heart was monitored for adverse changes throughout the course of the treatment and I was comfortable with the decision I made. When that choice is taken away due to non-disclosure, it is an assault and is inexcusable. It is very clear that this company’s main concern is for their own financial gain and that of their stockholders, with no regard for individuals suffering possible permanent side affects from their drug. There are other treatment options for breast cancer patients, including types of chemotherapy that do not cause permanent hair loss. Unfortunately, we were robbed of those options; stripped of the opportunity to make a different choice because of a simple lack of disclosure. It is clear that Sanofi-Aventis, the largest pharmaceutical company in Europe, third largest in the world, made a conscious decision to omit this information from their literature and to conveniently not provide doctors with the facts. This was intentional and the reason is clear; financial gain. They know that women care immensely about their appearance and that hair is an extremely important part of that; otherwise there would not be a multi-billion dollar industry built around hair and hair products. So, how many of those women would opt. for Taxotere as opposed to another drug, if they knew the facts? We are looking for support in our efforts to put a stop to this industry giant as they continue to pedal their drug to unsuspecting potential victims.